Annual Retained Earnings
-$752.95 M
-$151.09 M-25.10%
31 December 2023
Summary:
Centessa Pharmaceuticals annual retained earnings is currently -$752.95 million, with the most recent change of -$151.09 million (-25.10%) on 31 December 2023. During the last 3 years, it has fallen by -$730.52 million (-3257.91%). CNTA annual retained earnings is now -1629.48% below its all-time high of $49.23 million, reached on 01 June 2020.CNTA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$877.37 M
-$42.57 M-5.10%
30 September 2024
Summary:
Centessa Pharmaceuticals quarterly retained earnings is currently -$877.37 million, with the most recent change of -$42.57 million (-5.10%) on 30 September 2024. Over the past year, it has dropped by -$161.26 million (-22.52%). CNTA quarterly retained earnings is now -260.65% below its all-time high of -$243.27 million, reached on 31 March 2021.CNTA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTA Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -25.1% | -22.5% |
| 3 y3 years | -3257.9% | -170.1% |
| 5 y5 years | -1846.0% | - |
CNTA Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -3257.9% | at low | -170.1% | at low |
| 5 y | 5 years | -1629.5% | at low | -260.6% | at low |
| alltime | all time | -1629.5% | at low | -260.6% | at low |
Centessa Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$877.37 M(+5.1%) |
| June 2024 | - | -$834.81 M(+5.5%) |
| Mar 2024 | - | -$790.99 M(+5.1%) |
| Dec 2023 | -$752.95 M(+25.1%) | -$752.95 M(+5.1%) |
| Sept 2023 | - | -$716.11 M(+5.7%) |
| June 2023 | - | -$677.46 M(+3.8%) |
| Mar 2023 | - | -$652.57 M(+8.4%) |
| Dec 2022 | -$601.86 M(+56.1%) | -$601.86 M(+7.7%) |
| Sept 2022 | - | -$558.69 M(+10.7%) |
| June 2022 | - | -$504.81 M(+14.7%) |
| Mar 2022 | - | -$440.15 M(+14.1%) |
| Dec 2021 | -$385.65 M | -$385.65 M(+18.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -$324.88 M(+14.1%) |
| June 2021 | - | -$284.72 M(+17.0%) |
| Mar 2021 | - | -$243.27 M |
| Dec 2020 | -$22.42 M(-145.5%) | - |
| June 2020 | $49.23 M(+14.2%) | - |
| June 2019 | $43.12 M(+177.3%) | - |
| June 2018 | $15.55 M(-168.4%) | - |
| June 2017 | -$22.74 M(-17.6%) | - |
| June 2016 | -$27.60 M(-14.6%) | - |
| June 2015 | -$32.31 M(+6431.2%) | - |
| May 2015 | -$494.70 K(-2.8%) | - |
| May 2014 | -$508.90 K | - |
FAQ
- What is Centessa Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual retained earnings year-on-year change?
- What is Centessa Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly retained earnings year-on-year change?
What is Centessa Pharmaceuticals annual retained earnings?
The current annual retained earnings of CNTA is -$752.95 M
What is the all time high annual retained earnings for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual retained earnings is $49.23 M
What is Centessa Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, CNTA annual retained earnings has changed by -$151.09 M (-25.10%)
What is Centessa Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of CNTA is -$877.37 M
What is the all time high quarterly retained earnings for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly retained earnings is -$243.27 M
What is Centessa Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, CNTA quarterly retained earnings has changed by -$161.26 M (-22.52%)